For professionals in the pharmaceutical industry, detailed knowledge of chemical intermediates is crucial for successful drug development and manufacturing. 2-Aminoindan, a key component in the synthesis of Indacaterol, possesses a specific set of physical and chemical properties that dictate its utility. Understanding these specifications is the first step towards leveraging this compound effectively.

The chemical identity of 2-Aminoindan is firmly established with its CAS Number 2975-41-9. Its molecular formula is C9H11N, and it has a molecular weight of 133.190. Physically, it is described as a dark purple liquid, a characteristic that aids in its identification. The density is reported as approximately 1.1 g/cm³, and its boiling point is around 226.2 °C at 760 mmHg, with a flash point of 96.8 °C. These physical properties are important for handling, storage, and process design.

However, for pharmaceutical applications, the critical specifications are the purity and consistency of the intermediate. 2-Aminoindan is typically supplied with an assay of ≥98.0%. This high level of purity ensures that the compound will behave predictably in chemical reactions and minimizes the risk of contaminants affecting the final product, such as Indacaterol. Furthermore, the moisture content is kept low, usually ≤0.5%, which is vital for maintaining the stability and reactivity of the compound in various synthesis steps.

When companies decide to buy 2-Aminoindan, they are looking for a product that meets these stringent parameters. Reputable suppliers, such as Ningbo Inno Pharmchem Co., Ltd., provide detailed certificates of analysis that confirm these specifications. Access to accurate 2-aminoindan chemical properties data is essential for R&D chemists and process engineers to design efficient and robust manufacturing processes.

In summary, the specifications of 2-Aminoindan are not merely technical details; they are the foundation upon which the quality of Indacaterol production is built. Adherence to these standards ensures the reliability and efficacy of the final therapeutic product.